A detailed history of Sienna Gestion transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sienna Gestion holds 18,019 shares of VRTX stock, worth $8.55 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
18,019
Holding current value
$8.55 Million
% of portfolio
0.69%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $7.35 Million - $8.04 Million
18,019 New
18,019 $7.53 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sienna Gestion Portfolio

Follow Sienna Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sienna Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Sienna Gestion with notifications on news.